SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-046449
Filing Date
2020-08-12
Accepted
2020-08-12 18:28:13
Documents
1
Period of Report
2020-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8687
  Complete submission text file 0001209191-20-046449.txt   10088
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 350 CAMBRIDGE AVENUE, SUITE 350 PALO ALTO CA 94306
Business Address
Glenn Jeffrey S (Reporting) CIK: 0001670382 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36183 | Film No.: 201096512